iifl-logo-icon 1

Sanjivani Paranteral Ltd Share Price

201
(0.63%)
Jul 23, 2024|10:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open204.85
  • Day's High204.85
  • 52 Wk High232.85
  • Prev. Close199.75
  • Day's Low194
  • 52 Wk Low62.21
  • Turnover (lac)13.11
  • P/E37.83
  • Face Value10
  • Book Value23.87
  • EPS5.28
  • Mkt. Cap (Cr.)234.85
  • Div. Yield0
No Records Found

Sanjivani Paranteral Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

204.85

Prev. Close

199.75

Turnover(Lac.)

13.11

Day's High

204.85

Day's Low

194

52 Week's High

232.85

52 Week's Low

62.21

Book Value

23.87

Face Value

10

Mkt Cap (₹ Cr.)

234.85

P/E

37.83

EPS

5.28

Divi. Yield

0

Sanjivani Paranteral Ltd Corporate Action

6 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

6 Sep 2023

12:00 AM

BookCloser

arrow

26 Dec 2023

12:00 AM

EGM

arrow

6 Sep 2023

12:00 AM

AGM

Announcement Date: 06 Sep, 2023

arrow

Sanjivani Paranteral Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sanjivani Paranteral Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|10:40 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 27.67%

Foreign: 0.00%

Indian: 27.67%

Non-Promoter- 9.71%

Institutions: 9.70%

Non-Institutions: 62.62%

Custodian: 0.00%

Share Price

Sanjivani Paranteral Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

10

10

8.5

5.9

Preference Capital

0

0

0

0

Reserves

-13.07

-17.58

-53.39

-54.81

Net Worth

-3.07

-7.58

-44.89

-48.91

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

25.09

16.35

17.95

32.66

yoy growth (%)

53.46

-8.92

-45.02

-71.71

Raw materials

-14.8

-9.06

-25.38

-28.15

As % of sales

58.98

55.43

141.36

86.19

Employee costs

-2.49

-2.61

-2.96

-2.77

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

1.41

-1.8

-53.37

-26.41

Depreciation

-0.85

-1.07

-1.19

-1.19

Tax paid

0

0.1

0.31

0.19

Working capital

2.96

8.78

-54.83

-23.02

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

53.46

-8.92

-45.02

-71.71

Op profit growth

-744.32

-99.36

124.45

321.48

EBIT growth

-233.46

-97.82

144.81

251.42

Net profit growth

-183.08

-96.78

102.35

79.09

View Ratios

No Record found

Sanjivani Paranteral Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.9

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.75

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,489.7

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.4

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,769.25

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Sanjivani Paranteral Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Ashwin Khemka

Independent Director

Mrunmai M Sarvankar

Independent Director

Monika Singhania

Executive Director

Srivardhan Ashwani Khemka

Company Sec. & Compli. Officer

Pooja Vijay Gohil

Additional Director

ABHAY SHAH

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun.Incorporated as a public limited company in Oct.94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Companys products includes oral solids, small volume parenteral and sterile powder formulations.The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.96 to part-finance the project.The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year production of liquid vials and ampules.During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hop
Read More

Company FAQs

What is the Sanjivani Paranteral Ltd share price today?

Down Arrow

The Sanjivani Paranteral Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹201 today.

What is the Market Cap of Sanjivani Paranteral Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sanjivani Paranteral Ltd is ₹234.85 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Sanjivani Paranteral Ltd?

Down Arrow

The PE and PB ratios of Sanjivani Paranteral Ltd is 37.83 and 8.37 as of 23 Jul ‘24

What is the 52 Week High and Low of Sanjivani Paranteral Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Sanjivani Paranteral Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sanjivani Paranteral Ltd is ₹62.21 and ₹232.85 as of 23 Jul ‘24

What is the CAGR of Sanjivani Paranteral Ltd?

Down Arrow

Sanjivani Paranteral Ltd's CAGR for 5 Years at 89.43%, 3 Years at 92.73%, 1 Year at 202.19%, 6 Month at 24.07%, 3 Month at 3.07% and 1 Month at -0.05%.

What is the shareholding pattern of Sanjivani Paranteral Ltd?

Down Arrow

The shareholding pattern of Sanjivani Paranteral Ltd is as follows:
Promoters - 27.67 %
Institutions - 9.70 %
Public - 62.63 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.